Surgery Partners Q1 2024 Earnings Report
Key Takeaways
Surgery Partners reported a 7.7% increase in revenue to $717.4 million and an Adjusted EBITDA of $97.5 million, representing an 8.2% growth compared to the prior year period. The company raised its full-year guidance to at least $3.05 billion in revenue and at least $505 million in Adjusted EBITDA.
Revenues increased 7.7% to $717.4 million compared to the prior year period.
Same-facility revenues increased 10.2%.
Adjusted EBITDA was $97.5 million, representing 8.2% growth compared to the prior year period.
Full year guidance raised to at least $3.05 billion in revenue and at least $505 million in Adjusted EBITDA.
Surgery Partners
Surgery Partners
Forward Guidance
The Company raised its outlook for 2024 revenues to be at least $3.05 billion and projects 2024 Adjusted EBITDA to be at least $505 million.
Positive Outlook
- Revenue to be at least $3.05 billion
- Adjusted EBITDA to be at least $505 million